PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.




PMID- 29514037
OWN - NLM
STAT- MEDLINE
DCOM- 20180312
LR  - 20180313
IS  - 1533-4406 (Electronic)
IS  - 0028-4793 (Linking)
VI  - 378
IP  - 10
DP  - 2018 Mar 8
TI  - Effects of Sotagliflozin Added to Insulin in Type 1 Diabetes.
PG  - 967-968
LID - 10.1056/NEJMc1800394 [doi]
FAU - Garg, Satish K
AU  - Garg SK
AD  - University of Colorado Denver, Aurora, CO [email protected]
FAU - Strumph, Paul
AU  - Strumph P
AD  - Lexicon Pharmaceuticals, The Woodlands, TX
LA  - eng
PT  - Letter
PT  - Comment
PL  - United States
TA  - N Engl J Med
JT  - The New England journal of medicine
JID - 0255562
RN  - 0 (Blood Glucose)
RN  - 0 (Glycated Hemoglobin A)
RN  - 0 (Hypoglycemic Agents)
RN  - 0 (Insulin)
SB  - AIM
SB  - IM
CON - . PMID: 29517210
CON - . PMID: 29517211
CON - . PMID: 29517212
CON - . PMID: 29517213
MH  - Blood Glucose
MH  - *Diabetes Mellitus, Type 1
MH  - Drug Therapy, Combination
MH  - Glycated Hemoglobin A/analysis
MH  - Humans
MH  - Hypoglycemic Agents
MH  - *Insulin
MH  - Treatment Outcome
EDAT- 2018/03/08 06:00
MHDA- 2018/03/13 06:00
CRDT- 2018/03/08 06:00
PHST- 2018/03/08 06:00 [entrez]
PHST- 2018/03/08 06:00 [pubmed]
PHST- 2018/03/13 06:00 [medline]
AID - 10.1056/NEJMc1800394 [doi]
AID - 10.1056/NEJMc1800394#SA5 [pii]
PST - ppublish
SO  - N Engl J Med. 2018 Mar 8;378(10):967-968. doi: 10.1056/NEJMc1800394.